Tags

Type your tag names separated by a space and hit enter

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
Lancet Infect Dis. 2021 08; 21(8):1071-1072.LI

Links

PMC Free PDF

Authors+Show Affiliations

Chen Y
Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.
Shen H
Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China.
Huang R
Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.
Tong X
Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China.
Wu C
Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu 210008, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210008, China. Electronic address: dr.wu@nju.edu.cn.

MeSH

AdolescentAdultAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesChinaFemaleHEK293 CellsHealthy VolunteersHumansImmunogenicity, VaccineLongitudinal StudiesMaleMiddle AgedMutationProspective StudiesSARS-CoV-2Spike Glycoprotein, CoronavirusTreatment OutcomeVaccines, InactivatedYoung Adult

Pub Type(s)

Letter
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34051887

Citation

Chen, Yuxin, et al. "Serum Neutralising Activity Against SARS-CoV-2 Variants Elicited By CoronaVac." The Lancet. Infectious Diseases, vol. 21, no. 8, 2021, pp. 1071-1072.
Chen Y, Shen H, Huang R, et al. Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. Lancet Infect Dis. 2021;21(8):1071-1072.
Chen, Y., Shen, H., Huang, R., Tong, X., & Wu, C. (2021). Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. The Lancet. Infectious Diseases, 21(8), 1071-1072. https://doi.org/10.1016/S1473-3099(21)00287-5
Chen Y, et al. Serum Neutralising Activity Against SARS-CoV-2 Variants Elicited By CoronaVac. Lancet Infect Dis. 2021;21(8):1071-1072. PubMed PMID: 34051887.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac. AU - Chen,Yuxin, AU - Shen,Han, AU - Huang,Rui, AU - Tong,Xin, AU - Wu,Chao, Y1 - 2021/05/27/ PY - 2021/04/20/received PY - 2021/05/07/revised PY - 2021/05/07/accepted PY - 2021/5/31/pubmed PY - 2021/8/18/medline PY - 2021/5/30/entrez SP - 1071 EP - 1072 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 21 IS - 8 SN - 1474-4457 UR - https://www.unboundmedicine.com/medline/citation/34051887/Serum_neutralising_activity_against_SARS_CoV_2_variants_elicited_by_CoronaVac_ DB - PRIME DP - Unbound Medicine ER -